prazosin has been researched along with Gastric Diseases in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsu, DZ | 1 |
Wang, ST | 1 |
Deng, JF | 1 |
Liu, MY | 1 |
Bhandare, PN | 1 |
Rataboli, PV | 1 |
Diniz D'Souza, RS | 1 |
Dhume, VG | 1 |
2 other studies available for prazosin and Gastric Diseases
Article | Year |
---|---|
Epinephrine protects against severe acute gastric bleeding in rats: role of nitric oxide and glutathione.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Enzyme Inhibitors; Epinephrine; Gastric Mucosa; | 2005 |
Aggravating action of hydralazine on ethanol-induced gastric lesions.
Topics: Animals; Captopril; Drug Interactions; Ethanol; Gastrointestinal Hemorrhage; Hydralazine; Male; Praz | 1992 |